Dear Investor Friends:

Please join us for an invitation only virtual private investor meeting on Zoom, featuring ARC Medical, on Wednesday, December 10th, 2025.

ARC is one of the most exciting life sciences companies we have seen! ARC significantly improves surgical patient recovery by preventing internal adhesions, the most common complication in knee, shoulder, gynecological and abdominal surgeries.

ARC is completing its $5M raise by mid-January, after which they plan to accept a $25 million term sheet for their B round.

Key Investment Considerations

• Massive Markets: 11 million patients yearly and a TAM $11 billion

• Excellent Efficacy and Clinical Data: for company’s lead products for knee and shoulder surgeries

• Strong IP Provide Exclusivity: multiple patents granted that provide exclusivity for the company’s products through 2039 and beyond.

• Great Fundrasing traction: ARC has already raised $39 million ($21M in equity and $18M in non-dilutive revenue and grants), and will close the current round in a matter of weeks.

• Unicorn-level Exit Potential: representing a 20X return based on comparable companies in the wound healing arena.

• World Class Team: has designed, developed multi $billion products for companies including J&J, Stryker, Smith+Nephew, Amgen and Moderna

Event Details:

📍Online via Zoom

🗓 December 10, 2025 | 11:30 AM EST

Please note that this meeting is for DIRECT and ACTIVE investors only. All RSVPs must be pre-registered on this Eventbrite site with the investor criteria filled out. All RSVPs are subject to review and approval.

This event is exclusively limited to invited UHNW/HNW investors, family offices, accredited investors, and financial advisors.

Request investor materials by contacting Skylar Rallison at srallison@opus8.com

Thanks much and all the best,

The Opus8 Team